The Official Report is a written record of public meetings of the Parliament and committees.
All Official Reports of meetings in the Debating Chamber of the Scottish Parliament.
All Official Reports of public meetings of committees.
Displaying 2585 contributions
Meeting of the Parliament [Draft]
Meeting date: 18 December 2025
Emma Harper
Absolutely. The twisting of the information is just a distraction from what is happening: the money is going predominantly to English fishermen when most of the quota is landed in Scotland.
A total of 9,000 tonnes is landed annually at South Scotland ports. That might be a small amount in comparison with some of the big ports, and I absolutely agree with Karen Adam when she describes how the allocation is going to impact the north-east. However, it is still an issue in South Scotland, as fishing in the south-west contributes a massive amount to the local economy and to the few jobs that we have.
We need to impress on the UK Government that the policy must be changed. It is a policy choice and it harms all our communities across Scotland, including those in Dumfries and Galloway.
Rural Affairs and Islands Committee [Draft]
Meeting date: 17 December 2025
Emma Harper
Okay—thanks.
Rural Affairs and Islands Committee [Draft]
Meeting date: 17 December 2025
Emma Harper
I think that we have been round and round the houses for long enough. We need to emphasise that, if the SSI is not passed, the Scottish agriculture budget will be funding English producer organisations. Our budget needs to be protected so that we can support our own producers, with the money being used to diversify and support other producers.
Rural Affairs and Islands Committee [Draft]
Meeting date: 17 December 2025
Emma Harper
Good morning. You have answered the questions that I was thinking about asking. I have written notes in my notebook about food security and resilience—you mentioned resilience a few times in your responses to Ariane Burgess.
There are three main producer organisations in Scotland, and other people are collaborating, such as the Scottish Seaweed Industry Association. There are different routes for other people to seek funding and support. Basically, are you saying that this is about the fruit and vegetable producer organisations getting the support that they absolutely need to provide resilience in food production, and that there are other mechanisms of support for other smaller producers?
Rural Affairs and Islands Committee [Draft]
Meeting date: 17 December 2025
Emma Harper
You are saying that we should also explore opportunities to support other growers, such as small market gardeners, using other mechanisms.
Rural Affairs and Islands Committee [Draft]
Meeting date: 17 December 2025
Emma Harper
I am going back a bit in the discussion, but the minister used the acronym “ENICs”. For the purposes of the Official Report, that is the employer national insurance contributions, which were increased by the UK Government, which has added another barrier for the producer organisations. I want to clarify that that is what you meant by that acronym.
Rural Affairs and Islands Committee [Draft]
Meeting date: 17 December 2025
Emma Harper
We do not have any control over setting those rates in Scotland.
Meeting of the Parliament
Meeting date: 17 December 2025
Emma Harper
Michelle Thomson mentioned cross-portfolio working. Repopulation is really important, including for Dumfries and Galloway. Will the Government maintain its commitment to that work after May 2026?
Health, Social Care and Sport Committee
Meeting date: 16 December 2025
Emma Harper
Does that mean that, if someone is going to administer a dermal filler, they will need to have the antidote on site? Time is critical if the blood supply to someone’s upper lip has been injected instead of the tissue around it. That would mean that the antidote would need to be readily available at whatever site is determined to be a Healthcare Improvement Scotland-regulated clinic.
Health, Social Care and Sport Committee
Meeting date: 16 December 2025
Emma Harper
On the back of the questions from Joe FitzPatrick and Sandesh Gulhane, I note that hyaluronic acid is a dermal filler that is registered as a medical device by the Medicines and Healthcare products Regulatory Agency, whereas the antidote, hyaluronidase, must be prescribed. There could be an issue with that. Osteopaths who are not medically trained do not prescribe, but they can give a device. Does that create a problem? If so, what work is being done with the MHRA to examine how we regulate that device? I note that it is not actually a device but a medication that has to be injected.